Full Press Release Details
PHILADELPHIA, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announced two digital posters for presentation at the 14th International Congress of Inborn Errors of Metabolism (ICIEM) being held virtually and in Sydney, Australia, November 21-23, 2021.
Digital Poster Presentations:
Long-term multisystemic efficacy with migalastat in ERT-naïve and ERT-experienced patients with amenable GLA variants Presenter: Drago Bratkovic, MD, PARC Research Clinic, Adelaide, Australia
Incidence and prevalence of newborn, paediatric, and adolescent patients with Fabry disease: a targeted literature review Presenter: Ian Keyzor, Amicus Therapeutics, Marlow, United Kingdom
The posters can be accessed via the Investors section of the Amicus Therapeutics corporate website at ir.amicusrx.com.
For more information on the International Congress of Inborn Errors of Metabolism 2021, please visit www.iciem2021.com.au.
About Amicus Therapeutics
Executive Director, Investor Relations
Head of Global Corporate Affairs & Communications